This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Quality Systems Ties Up With CoverMyMeds to Enable ePA
by Zacks Equity Research
Quality Systems' (QSII) new collaboration with CoverMyMeds sees bright market prospects.
Quality Systems (QSII) Up 6.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Quality Systems (QSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quality Systems (QSII) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Quality Systems (QSII) gains from solid bookings in Q2; growing pipeline encourages.
Quality Systems (QSII) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Quality Systems (QSII) delivered earnings and revenue surprises of 5.56% and 0.37%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Medical Product Stock Earnings on Jul 31: HOLX, NUVA, QSII
by Zacks Equity Research
Let's take a look at the factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.
CPSI vs. QSII: Which Stock Is the Better Value Option?
by Zacks Equity Research
CPSI vs. QSII: Which Stock Is the Better Value Option?
CPSI or QSII: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CPSI vs. QSII: Which Stock Is the Better Value Option?
CPSI or QSII: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CPSI vs. QSII: Which Stock Is the Better Value Option?
Company News For May 29, 2018
by Zacks Equity Research
Companies In The News are: FL,GPS,QSII,DECK
Quality Systems (QSII) Jumps: Stock Rises 12.9%
by Zacks Equity Research
Quality Systems (QSII) shares rose nearly 13% in the last trading session, amid huge volumes.
Quality Systems (QSII) Q4 Earnings Beat, Bookings Rise Y/Y
by Zacks Equity Research
Quality Systems (QSII) exits fourth quarter on a solid note with a surge in bookings; issues a solid guidance for fiscal 2019.
Quality Systems (QSII) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Lucrative prospects in RCM, solid recurring revenue base and strong demand for NextGen solutions are likely to drive Quality Systems' (QSII) top line in Q4.
What's in Store for Veeva Systems (VEEV) in Q1 Earnings?
by Zacks Equity Research
Veeva Systems' (VEEV) Q1 earnings to benefit from growing demand for cloud-based and vault applications, new product launches, industry focus approach along with international expansion.
Will Core Distribution Unit Aid McKesson (MCK) Q4 Earnings?
by Zacks Equity Research
McKesson's (MCK) Q4 results likely to be driven by core segmental performance; solid view and new growth initiatives buoy optimism.
What's in Store for Patterson Companies' (PDCO) Q4 Earnings?
by Zacks Equity Research
Patterson's (PDCO) Dental segment likely to see a soft Q4; a downbeat guidance raises concern.
MedTech Takes to Big Data Analytics: 3 Stocks Catch Eye
by Nabaparna Bhattacharya
Here we take a look at the major factors that are driving the importance of big data in the MedTech space.
Why Is Quality Systems (QSII) Down 7.5% Since its Last Earnings Report?
by Zacks Equity Research
Quality Systems (QSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quality Systems (QSII) Q3 Earnings in Line, Revenues Beat
by Zacks Equity Research
Quality Systems (QSII) benefits from solid bookings and acquisitions in Q3.
Henry Schein Buys eVetPractice, Boosts Technology & VAS Arm
by Zacks Equity Research
Henry Schein (HSIC) adopts initiatives to strengthen hold in the high-potential healthcare IT market.
Quality Systems (QSII) Beats on Earnings & Revenues in Q2
by Zacks Equity Research
Quality Systems' (QSII) solid total software, hardware revenues drove second-quarter earnings. A solid recurring revenue base is a key catalyst for the quarters to come.
Henry Schein MicroMD Software Gets ONC-Health IT Certificate
by Zacks Equity Research
Henry Schein's (HSIC) MicroMD receives ONC-Health IT Certificate from Drummond Group, boosting the company's technology and value-added service business.
Quality Systems (QSII) Down 10.5% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Quality Systems (QSII) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quality Systems Professional Service a Drag, Competition Rife
by Zacks Equity Research
Quality Systems' (QSII) performance in the professional service business continues to be a drag in recent times. Also, macro headwinds continue to put pressure on performance.
Quality Systems (QSII) Completes EagleDream Health Buyout
by Zacks Equity Research
In line with its acquisition spree, Quality Systems's (QSII) subsidiary NextGen Healthcare Information Systems buys EagleDream Health.
Quality Systems (QSII) Beats on Q1 Earnings, Revenues
by Zacks Equity Research
Quality Systems (QSII) recorded stellar growth in its recurring revenue base in the first quarter. However, a downbeat guidance for adjusted earnings indicates looming concerns.